Mestinon

Pyridostigmine bromide, the active ingredient in Mestinon, is an acetylcholinesterase inhibitor presented as an oral tablet for oral use. It is employed to improve neuromuscular transmission in myasthenia gravis and may be used in postoperative ileus and orthostatic hypotension management.

GNH USA supplies Mestinon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mestinon is an acetylcholinesterase inhibitor used in disorders where enhanced neuromuscular transmission is required.

- Myasthenia gravis: improves muscle strength by increasing acetylcholine at the neuromuscular junction. - Postoperative ileus: stimulates intestinal motility to aid recovery after surgery. - Orthostatic hypotension (off‑label): supports blood pressure regulation by augmenting autonomic cholinergic activity.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: increased bowel movements. - Abdominal cramps: discomfort in the stomach area. - Excessive salivation: increased oral secretions. - Muscle cramps: involuntary tightening of skeletal muscles. - Sweating: heightened perspiration.

Serious or Rare Side Effects: - Cholinergic crisis: severe muscle weakness and respiratory compromise. - Bradycardia: markedly slow heart rate. - Bronchospasm: narrowing of airways causing breathing difficulty. - Seizures: uncontrolled electrical activity in the brain. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Prolonged QT interval: potential cardiac rhythm disturbance.

Before initiating therapy, clinicians should consider several safety aspects.

- Renal impairment: adjust dose because the drug is primarily excreted unchanged. - History of asthma or COPD: monitor for bronchospasm. - Concomitant anticholinesterases: avoid additive cholinergic effects. - Cardiovascular disease: watch for bradycardia or arrhythmias. - Pregnancy and lactation: safety data are limited; use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pyridostigmine bromide can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Other anticholinesterases (e.g., neostigmine, physostigmine): risk of cholinergic overload. - Beta‑adrenergic blockers: may mask tachycardia caused by cholinergic excess. - Magnesium sulfate: potentiates neuromuscular blockade.

Moderate Interactions (Monitor Closely): - Aminoglycoside antibiotics: may enhance neuromuscular weakness. - Beta‑2 agonists: could reduce the drug’s effectiveness on muscle strength. - Loop diuretics: may increase renal clearance, requiring dose adjustment.